Genmab To Initiate HuMax-Inflam Glioblastoma Trial In 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Other potential indications for the interleukin-8 antibody include chronic obstructive pulmonary disease.
You may also be interested in...
PDL Divests Another Business – Genmab Gets Antibody Facility For $240 Million
Danish firm adds capacity to produce clinical and commercial scale material for its pipeline.
PDL Divests Another Business – Genmab Gets Antibody Facility For $240 Million
Danish firm adds capacity to produce clinical and commercial scale material for its pipeline.
Genentech Reports Positive Progression-Free Survival Results For Avastin In Brain Cancer Trial
Interim results of a Phase II study showed that 51 percent of patients receiving Avastin plus chemotherapy experienced six months of PFS, and 36 percent of patients taking Avastin alone had six-month PFS.